Lymph Node Analysis Could Improve Melanoma Treatment Options
Studies are demonstrating the potential of the Parsortix system to enhance laboratory efficiency, reduce costs, support medical decisionmaking, and improve patient care.
Read MorePosted by Chaunie Brusie | Mar 4, 2019 | Melanoma, Research |
Studies are demonstrating the potential of the Parsortix system to enhance laboratory efficiency, reduce costs, support medical decisionmaking, and improve patient care.
Read MorePosted by Steve Halasey | Jan 31, 2019 | Lung Cancer |
The companies’ collaboration underscores the need for proteomic data to enable precision medicine strategies for lung cancer patients.
Read MorePosted by Steve Halasey | Jan 17, 2019 | Lung Cancer |
If approved, the test could be the first FDA-approved multigene sequencing-based in vitro diagnostic to accept both plasma and FFPE-based inputs.
Read MorePosted by Steve Halasey | Jan 11, 2019 | Lung Cancer |
The assay enables researchers to measure tumor mutational burden and microsatellite instability, and detect other known and emerging biomarkers.
Read MorePosted by Steve Halasey | Jan 10, 2019 | Research, Specimen Collection & Handling |
With three NCI grants, BioFluidica is investigating chip-based liquid biopsy technologies for the detection of cancer and related genetic variants.
Read More